机构:[a]Aneurin Bevan University Health Board, Royal Gwent Hospital, Cardiff Road, Newport, NP20 5UB, UK[b]Queen Mary University of London, London, EC1M 6BQ, UK[c]Sanyu Africa Research Institute (SAfRI), Mbale Regional Referral Hospital, Uganda[d]Department of Anesthesiology and Intensive Care Medicine, Northern State Medical University, Arkhangelsk, Russia[e]Department of Anesthesiology and Intensive Care Medicine, Russian Scientific and Research Medical University, Moscow, Russia[f]Department of Anaesthesia, College of Medicine, University of Ibadan/University College Hospital, Ibadan, Nigeria[g]Department of Visceral Surgery, University Hospital Lausanne, Lausanne, Switzerland[h]Department of Visceral Surgery, CHU Angers, 4 Rue Larrey, 49933, Angers, France
Aims: Previous research suggests that patients undergoing upper gastrointestinal surgery are at high risk of poor postoperative outcomes. The aim of our study was to describe patient outcomes after elective upper gastrointestinal surgery at a global level. Methods: Prospective analysis of data collected during an international seven-day cohort study of 474 hospitals in 27 countries. Patients undergoing elective upper gastrointestinal. surgery were recruited. Outcome measures were in-hospital complications and mortality at 30-days. Results are presented as n(%) and odds ratios with 95% confidence intervals. Results: 2139 patients were included, of whom 498 (23.2%) developed one or more postoperative complications, with 30 deaths (1.4%). Patients with complications had longer median hospital stay 11 (6-18) days vs. 5 (2-10) days. Infectious complications were most frequent, affecting 368 (17.2%) patients. 328 (15.3%) patients were admitted to critical care postoperatively, of whom 161 (49.1%) developed a complication with 14 deaths (4.3%). In a multivariable logistic regression model we identified age (OR 1.02 [1.01-1.03]), American Society of Anesthesiologists physical status III (OR 2.12 [1.44-3.16]) and IV (OR 3.23 [1.72-6.09]), surgery for cancer (OR 1.63 [1.27-2.11]), open procedure (OR 1.40 [1.10-1.78]), intermediate surgery (OR 1.75 [1.12-2.81]) and major surgery (OR 2.65 [1.72-4.23]) as independent risk factors for postoperative complications. Patients undergoing major surgery for upper gastrointestinal cancer experienced twice the rate of complications compared to those undergoing other procedures (224/578 patients [38.8%] versus 274/1561 patients [17.6%]). Conclusions: Complications and death are common after upper gastrointestinal surgery. Patients undergoing major surgery for cancer are at greatest risk. (C) 2017 Elsevier Ltd, BASO similar to The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
基金:
Nestle Health Sciences; National Institute for Health Research (UK); Queen Mary University of London
第一作者机构:[a]Aneurin Bevan University Health Board, Royal Gwent Hospital, Cardiff Road, Newport, NP20 5UB, UK[*1]Critical Care Directorate Royal Gwent Hospital Cardiff Road Newport NP20 2UB United Kingdom
通讯作者:
通讯机构:[*1]Critical Care Directorate Royal Gwent Hospital Cardiff Road Newport NP20 2UB United Kingdom
推荐引用方式(GB/T 7714):
T. Szakmany,J. Ditai,M. Kirov,et al.In-hospital clinical outcomes after upper gastrointestinal surgery: Data from an international observational study[J].EJSO.2017,43(12):doi:10.1016/j.ejso.2017.08.002.
APA:
T. Szakmany,J. Ditai,M. Kirov,D. Protsenko,B. Osinaike...&J.R. Prowle.(2017).In-hospital clinical outcomes after upper gastrointestinal surgery: Data from an international observational study.EJSO,43,(12)
MLA:
T. Szakmany,et al."In-hospital clinical outcomes after upper gastrointestinal surgery: Data from an international observational study".EJSO 43..12(2017)